It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 | Hyderabad, Telangana, India | ActiveEubios Therapeutica (India) Private Limited, a active private limited company, was established on 17 August 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2009PTC064764. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Subba Rao Ambati (Director), Lakshmi Tulasi Ambati (Director). Past directors included Lakshmi Sujatha Ponnam. It holds no open charges and ₹4.80 M settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-1-31/304, Mahalakshmi Mansion Dharam Karan Road, Leela Nagar Centre,Am, Eerpet, Hyderabad, Telangana, 500016.
U24232TG2009PTC064764
064764
17 August 2009
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Eubios Therapeutica (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subba Rao Ambati | Director | 17 Aug 2009 | Current |
| Lakshmi Tulasi Ambati | Director | 17 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 01 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eubios Therapeutica (India) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 44.15% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Eubios Therapeutica (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹4,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2010 | Andhra Bank | ₹4.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Eubios Therapeutica (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eubios Therapeutica (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eubios Therapeutica (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eubios Therapeutica (India) Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
The activity Eubios Therapeutica (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge registered on 22 Apr 2010 via Charge ID 10215821 with Andhra Bank was fully satisfied on 14 Mar 2015. was completed.
The activity A charge with Andhra Bank of Rs. 0.48 Cr registered on 22 Apr 2010 with Charge ID 10215821 was modified on 12 Sep 2011. was completed.
Progress on A charge with Andhra Bank amounted to Rs. 0.48 Cr with Charge ID 10215821 was registered on 22 Apr 2010. was documented.
Progress on Subba Rao Ambati was appointed as a Director was appointed as a Director on 17 Aug 2009 & has been associated with this company since 16 years 3 months . was documented.
The CIN of Eubios Therapeutica (India) Private Limited is U24232TG2009PTC064764.
Eubios Therapeutica (India) Private Limited is headquartered at 7-1-31/304, Mahalakshmi Mansion Dharam Karan Road, Leela Nagar Centre,Am, Eerpet, Hyderabad, Telangana, 500016.
Eubios Therapeutica (India) Private Limited was incorporated on 17 August 2009.
The current directors of Eubios Therapeutica (India) Private Limited are
The primary industry of Eubios Therapeutica (India) Private Limited is Manufacturing.
Eubios Therapeutica (India) Private Limited is unlisted.
The authorized capital of Eubios Therapeutica (India) Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Eubios Therapeutica (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX